HUMAN GENE TRANSFER PROTOCOL 
9312-063 Sznol, Mario; National Institutes of Health, Frederick, Maryland; A Phase I 
Trial of B7 -Transfected Lethally Irradiated Allogeneic Melanoma Cell Lines 
to Induce Cell Mediated Immunity Against Tumor-Associated Antigens 
Presented by HLA-A2 or HLA-A1 in Patients with Stage TV Melanoma. 
Date of RAC Approval: 12/3/1993 
Date of NIH Approval: 4/19/1994 
[716] 
Recombinant DNA Research, Volume 18 
